Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Repair | 27 | 2024 | 2041 | 3.480 |
Why?
|
DNA Breaks, Double-Stranded | 19 | 2024 | 612 | 3.380 |
Why?
|
Phosphoprotein Phosphatases | 12 | 2019 | 328 | 2.860 |
Why?
|
MicroRNAs | 27 | 2024 | 3758 | 2.620 |
Why?
|
BRCA1 Protein | 11 | 2024 | 1149 | 2.160 |
Why?
|
Genomic Instability | 8 | 2024 | 709 | 1.990 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2024 | 111 | 1.530 |
Why?
|
DNA Damage | 22 | 2023 | 2443 | 1.370 |
Why?
|
RNA-Binding Proteins | 7 | 2024 | 1855 | 1.270 |
Why?
|
G1 Phase | 5 | 2019 | 403 | 1.260 |
Why?
|
Ovarian Neoplasms | 15 | 2024 | 4853 | 1.250 |
Why?
|
DNA | 15 | 2024 | 7189 | 1.200 |
Why?
|
DNA Replication | 8 | 2024 | 1415 | 1.050 |
Why?
|
Radiation Tolerance | 5 | 2018 | 478 | 0.990 |
Why?
|
Histones | 10 | 2023 | 2570 | 0.990 |
Why?
|
Cyclin B1 | 2 | 2024 | 57 | 0.970 |
Why?
|
Mitosis | 4 | 2024 | 1186 | 0.910 |
Why?
|
Multiprotein Complexes | 4 | 2024 | 1113 | 0.820 |
Why?
|
Nucleotidyltransferases | 1 | 2024 | 242 | 0.800 |
Why?
|
Granzymes | 6 | 2009 | 276 | 0.740 |
Why?
|
Cell Line, Tumor | 24 | 2024 | 16947 | 0.650 |
Why?
|
Cytoplasmic Dyneins | 1 | 2018 | 24 | 0.630 |
Why?
|
HeLa Cells | 10 | 2024 | 3073 | 0.580 |
Why?
|
Down-Regulation | 6 | 2016 | 2915 | 0.570 |
Why?
|
Protein Processing, Post-Translational | 4 | 2020 | 1967 | 0.530 |
Why?
|
Serum | 1 | 2017 | 208 | 0.530 |
Why?
|
Phosphorylation | 15 | 2020 | 8303 | 0.530 |
Why?
|
Protein Binding | 10 | 2024 | 9300 | 0.520 |
Why?
|
Whole-Body Irradiation | 2 | 2023 | 432 | 0.510 |
Why?
|
Phosphoproteins | 6 | 2024 | 2443 | 0.500 |
Why?
|
Genes, BRCA1 | 1 | 2018 | 754 | 0.480 |
Why?
|
Cisplatin | 2 | 2018 | 1651 | 0.460 |
Why?
|
Replication Protein A | 2 | 2014 | 53 | 0.460 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 407 | 0.460 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2024 | 2914 | 0.450 |
Why?
|
Conserved Sequence | 1 | 2017 | 1162 | 0.440 |
Why?
|
Cell Lineage | 2 | 2021 | 2547 | 0.440 |
Why?
|
DNA-Binding Proteins | 7 | 2024 | 9566 | 0.430 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2870 | 0.430 |
Why?
|
RNA Interference | 9 | 2019 | 2816 | 0.430 |
Why?
|
DNA Breaks | 1 | 2013 | 47 | 0.420 |
Why?
|
Radiation Injuries | 2 | 2018 | 1191 | 0.420 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5300 | 0.400 |
Why?
|
Lysine | 1 | 2017 | 983 | 0.400 |
Why?
|
Glioblastoma | 3 | 2016 | 3481 | 0.390 |
Why?
|
BRCA2 Protein | 5 | 2023 | 797 | 0.390 |
Why?
|
Transforming Growth Factor beta | 2 | 2016 | 1964 | 0.380 |
Why?
|
Exodeoxyribonucleases | 3 | 2007 | 191 | 0.370 |
Why?
|
Phthalazines | 3 | 2021 | 383 | 0.370 |
Why?
|
Cystadenocarcinoma, Serous | 3 | 2021 | 475 | 0.360 |
Why?
|
Carrier Proteins | 3 | 2021 | 4933 | 0.360 |
Why?
|
Lymphocytes | 3 | 2014 | 2603 | 0.340 |
Why?
|
Signal Transduction | 11 | 2024 | 23415 | 0.330 |
Why?
|
Pyrazines | 4 | 2024 | 1202 | 0.330 |
Why?
|
RNA, Untranslated | 1 | 2013 | 453 | 0.330 |
Why?
|
Cell Cycle Proteins | 7 | 2022 | 3443 | 0.320 |
Why?
|
RNA, Small Interfering | 9 | 2019 | 3409 | 0.310 |
Why?
|
Antineoplastic Agents | 6 | 2023 | 13630 | 0.310 |
Why?
|
Apoptosis | 8 | 2023 | 9478 | 0.310 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1882 | 0.310 |
Why?
|
Pancreatic Neoplasms | 2 | 2024 | 5366 | 0.300 |
Why?
|
Cell Death | 3 | 2009 | 1676 | 0.290 |
Why?
|
Membrane Proteins | 1 | 2024 | 7844 | 0.290 |
Why?
|
Isoxazoles | 3 | 2024 | 233 | 0.280 |
Why?
|
DNA Topoisomerases, Type II | 2 | 2022 | 121 | 0.280 |
Why?
|
Blood Cells | 1 | 2009 | 306 | 0.280 |
Why?
|
Nucleoside-Diphosphate Kinase | 1 | 2006 | 17 | 0.270 |
Why?
|
Cell Cycle | 6 | 2019 | 2926 | 0.270 |
Why?
|
Carcinoma | 1 | 2018 | 2328 | 0.270 |
Why?
|
Mutation | 14 | 2024 | 30006 | 0.260 |
Why?
|
Animals | 34 | 2024 | 168083 | 0.260 |
Why?
|
Humans | 80 | 2024 | 761098 | 0.250 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2019 | 655 | 0.250 |
Why?
|
HEK293 Cells | 4 | 2024 | 4250 | 0.250 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2018 | 359 | 0.240 |
Why?
|
Coenzymes | 1 | 2024 | 101 | 0.230 |
Why?
|
Serine Endopeptidases | 2 | 2006 | 1022 | 0.230 |
Why?
|
Mice | 22 | 2024 | 81324 | 0.230 |
Why?
|
Chromatin | 6 | 2023 | 2945 | 0.230 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2008 | 1351 | 0.230 |
Why?
|
S Phase | 2 | 2022 | 422 | 0.220 |
Why?
|
Repressor Proteins | 2 | 2012 | 2974 | 0.220 |
Why?
|
Poly(ADP-ribose) Polymerases | 4 | 2014 | 426 | 0.220 |
Why?
|
Genes, Immunoglobulin | 1 | 2004 | 285 | 0.210 |
Why?
|
Telomere-Binding Proteins | 3 | 2020 | 118 | 0.210 |
Why?
|
Deoxycytidine | 3 | 2024 | 878 | 0.210 |
Why?
|
Binding Sites | 4 | 2021 | 5993 | 0.210 |
Why?
|
Platinum | 3 | 2020 | 220 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3388 | 0.210 |
Why?
|
Immunity, Innate | 2 | 2024 | 3044 | 0.200 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2007 | 646 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2020 | 8529 | 0.200 |
Why?
|
Cell Line | 10 | 2020 | 15542 | 0.200 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2018 | 487 | 0.190 |
Why?
|
Feedback, Physiological | 1 | 2004 | 475 | 0.190 |
Why?
|
Piperazines | 2 | 2014 | 2522 | 0.190 |
Why?
|
Antigens, Nuclear | 2 | 2016 | 184 | 0.190 |
Why?
|
Neoplasms, Bone Tissue | 1 | 2020 | 7 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11732 | 0.180 |
Why?
|
K562 Cells | 4 | 2010 | 640 | 0.180 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2020 | 72 | 0.170 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2019 | 20 | 0.170 |
Why?
|
Pyrimidines | 3 | 2022 | 3026 | 0.170 |
Why?
|
Phosphoserine | 1 | 2019 | 203 | 0.160 |
Why?
|
Lim Kinases | 1 | 2019 | 8 | 0.160 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22129 | 0.160 |
Why?
|
Spodoptera | 2 | 2010 | 141 | 0.160 |
Why?
|
Tumor Suppressor Proteins | 4 | 2014 | 2802 | 0.160 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9416 | 0.160 |
Why?
|
Brain Neoplasms | 3 | 2018 | 9025 | 0.160 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2024 | 1726 | 0.150 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2018 | 27 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2024 | 4574 | 0.150 |
Why?
|
G-Quadruplexes | 1 | 2020 | 143 | 0.150 |
Why?
|
Phenylenediamines | 1 | 2018 | 88 | 0.140 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2018 | 104 | 0.140 |
Why?
|
Triage | 1 | 2024 | 984 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1404 | 0.140 |
Why?
|
Cell Division | 3 | 2012 | 4451 | 0.140 |
Why?
|
Benzoquinones | 2 | 2014 | 198 | 0.140 |
Why?
|
Cell Differentiation | 4 | 2010 | 11505 | 0.130 |
Why?
|
Models, Molecular | 2 | 2024 | 5413 | 0.130 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17598 | 0.130 |
Why?
|
RNA-Binding Protein EWS | 1 | 2018 | 210 | 0.130 |
Why?
|
Lupus Erythematosus, Cutaneous | 2 | 2007 | 73 | 0.130 |
Why?
|
Female | 23 | 2024 | 392458 | 0.130 |
Why?
|
Oncogenes | 2 | 2021 | 1220 | 0.130 |
Why?
|
Oligonucleotides, Antisense | 2 | 2016 | 457 | 0.130 |
Why?
|
Protein Transport | 2 | 2014 | 1959 | 0.130 |
Why?
|
Protein Subunits | 2 | 2010 | 941 | 0.130 |
Why?
|
Cell Nucleus | 2 | 2023 | 2881 | 0.130 |
Why?
|
RNA, Messenger | 7 | 2014 | 12743 | 0.130 |
Why?
|
G2 Phase | 2 | 2014 | 136 | 0.130 |
Why?
|
Lactams, Macrocyclic | 2 | 2014 | 318 | 0.130 |
Why?
|
Glioma | 2 | 2022 | 3452 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2012 | 987 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2194 | 0.120 |
Why?
|
Protein Phosphatase 2 | 2 | 2008 | 231 | 0.120 |
Why?
|
Receptors, Antigen | 2 | 2005 | 51 | 0.120 |
Why?
|
Base Sequence | 3 | 2016 | 12404 | 0.120 |
Why?
|
Gene Expression Regulation | 6 | 2017 | 11856 | 0.120 |
Why?
|
Proteome | 1 | 2024 | 1856 | 0.120 |
Why?
|
Methylation | 1 | 2017 | 1070 | 0.110 |
Why?
|
Comet Assay | 2 | 2012 | 75 | 0.110 |
Why?
|
Nuclear Proteins | 5 | 2020 | 5781 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2018 | 716 | 0.110 |
Why?
|
Salvage Therapy | 1 | 2020 | 1264 | 0.110 |
Why?
|
DNA Modification Methylases | 1 | 2014 | 210 | 0.110 |
Why?
|
Telomere | 1 | 2019 | 938 | 0.110 |
Why?
|
Rad51 Recombinase | 2 | 2013 | 189 | 0.110 |
Why?
|
3' Untranslated Regions | 3 | 2011 | 514 | 0.110 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 773 | 0.110 |
Why?
|
Perforin | 3 | 2008 | 166 | 0.110 |
Why?
|
Substrate Specificity | 2 | 2008 | 1768 | 0.110 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20120 | 0.100 |
Why?
|
Alleles | 1 | 2004 | 6857 | 0.100 |
Why?
|
Uterine Neoplasms | 1 | 2021 | 1420 | 0.100 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 346 | 0.100 |
Why?
|
Gene Silencing | 3 | 2008 | 1496 | 0.100 |
Why?
|
Mice, Knockout | 2 | 2024 | 14393 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1767 | 0.100 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2012 | 38 | 0.100 |
Why?
|
Loss of Heterozygosity | 1 | 2014 | 663 | 0.100 |
Why?
|
Cell Physiological Phenomena | 1 | 2013 | 149 | 0.100 |
Why?
|
Chromosome Breakage | 1 | 2012 | 159 | 0.100 |
Why?
|
Sequence Alignment | 1 | 2016 | 2175 | 0.090 |
Why?
|
Gene Library | 1 | 2014 | 1055 | 0.090 |
Why?
|
Radiation, Ionizing | 1 | 2012 | 252 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5662 | 0.090 |
Why?
|
Recombination, Genetic | 3 | 2012 | 1518 | 0.090 |
Why?
|
Neoplasms | 5 | 2024 | 22125 | 0.090 |
Why?
|
Immunoprecipitation | 2 | 2010 | 873 | 0.090 |
Why?
|
Macaca mulatta | 1 | 2017 | 2328 | 0.090 |
Why?
|
DNA-Activated Protein Kinase | 2 | 2012 | 112 | 0.090 |
Why?
|
Enzyme Inhibitors | 4 | 2014 | 3700 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1089 | 0.090 |
Why?
|
Pyrazoles | 1 | 2020 | 2010 | 0.090 |
Why?
|
E2F2 Transcription Factor | 1 | 2009 | 35 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2014 | 2468 | 0.080 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 13404 | 0.080 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2009 | 83 | 0.080 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2023 | 880 | 0.080 |
Why?
|
NF-kappa B | 1 | 2018 | 2475 | 0.080 |
Why?
|
Genes, cdc | 1 | 2009 | 114 | 0.080 |
Why?
|
Radiotherapy | 1 | 2016 | 1498 | 0.080 |
Why?
|
Hematopoietic System | 1 | 2009 | 110 | 0.080 |
Why?
|
Cell Proliferation | 6 | 2020 | 10421 | 0.080 |
Why?
|
Transcription Factors | 3 | 2020 | 12096 | 0.080 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2009 | 177 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 736 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1054 | 0.080 |
Why?
|
Aneuploidy | 1 | 2012 | 555 | 0.080 |
Why?
|
Endopeptidases | 1 | 2012 | 766 | 0.070 |
Why?
|
Bleomycin | 1 | 2009 | 494 | 0.070 |
Why?
|
Fibroblasts | 4 | 2019 | 4137 | 0.070 |
Why?
|
Gamma Rays | 1 | 2009 | 318 | 0.070 |
Why?
|
Computational Biology | 1 | 2020 | 3499 | 0.070 |
Why?
|
Baculoviridae | 1 | 2008 | 115 | 0.070 |
Why?
|
Antigens, Neoplasm | 2 | 2016 | 1984 | 0.070 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 57 | 0.070 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2007 | 91 | 0.070 |
Why?
|
Subcellular Fractions | 1 | 2008 | 525 | 0.070 |
Why?
|
Catalytic Domain | 1 | 2010 | 702 | 0.070 |
Why?
|
Protein Engineering | 2 | 2023 | 548 | 0.070 |
Why?
|
Models, Biological | 3 | 2012 | 9455 | 0.070 |
Why?
|
Chromosomes, Human | 1 | 2009 | 442 | 0.070 |
Why?
|
Antigens, Surface | 1 | 2011 | 1607 | 0.070 |
Why?
|
Protein Structure, Tertiary | 5 | 2014 | 3779 | 0.070 |
Why?
|
NM23 Nucleoside Diphosphate Kinases | 1 | 2006 | 21 | 0.070 |
Why?
|
Up-Regulation | 2 | 2021 | 4111 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 5318 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2017 | 2638 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2020 | 404 | 0.070 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2009 | 790 | 0.060 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2021 | 422 | 0.060 |
Why?
|
Genes, myc | 2 | 2020 | 390 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6817 | 0.060 |
Why?
|
Helminths | 1 | 2005 | 39 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2892 | 0.060 |
Why?
|
Doxorubicin | 1 | 2011 | 2224 | 0.060 |
Why?
|
Herpes Genitalis | 1 | 2005 | 149 | 0.060 |
Why?
|
Lung Neoplasms | 3 | 2016 | 13382 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12670 | 0.060 |
Why?
|
Herpesvirus 2, Human | 1 | 2005 | 191 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2413 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10083 | 0.060 |
Why?
|
Interferons | 3 | 2020 | 702 | 0.060 |
Why?
|
Mutation, Missense | 3 | 2009 | 2567 | 0.060 |
Why?
|
Models, Genetic | 1 | 2014 | 3430 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2020 | 11103 | 0.060 |
Why?
|
Recombinant Proteins | 3 | 2008 | 6507 | 0.060 |
Why?
|
Interleukin-7 | 1 | 2004 | 143 | 0.050 |
Why?
|
Adnexal Diseases | 1 | 2024 | 104 | 0.050 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2018 | 349 | 0.050 |
Why?
|
RNA Editing | 1 | 2005 | 149 | 0.050 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 781 | 0.050 |
Why?
|
Cytidine Deaminase | 1 | 2005 | 242 | 0.050 |
Why?
|
Immunoglobulin Variable Region | 1 | 2004 | 419 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 665 | 0.050 |
Why?
|
Adenosine Deaminase | 1 | 2005 | 250 | 0.050 |
Why?
|
Genetic Pleiotropy | 1 | 2024 | 181 | 0.050 |
Why?
|
Morpholines | 2 | 2018 | 581 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14676 | 0.050 |
Why?
|
Uridine | 1 | 2022 | 135 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6312 | 0.050 |
Why?
|
Telomerase | 2 | 2019 | 741 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1084 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9278 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4510 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2016 | 6123 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15308 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 101 | 0.050 |
Why?
|
Genome | 2 | 2019 | 1737 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2637 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2005 | 1125 | 0.040 |
Why?
|
Rats | 3 | 2019 | 23713 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1737 | 0.040 |
Why?
|
Cell Survival | 1 | 2010 | 5776 | 0.040 |
Why?
|
Aged | 7 | 2024 | 169266 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 1745 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2014 | 20981 | 0.040 |
Why?
|
Mammals | 1 | 2005 | 1131 | 0.040 |
Why?
|
Guanine | 1 | 2020 | 278 | 0.040 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2019 | 283 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 1703 | 0.040 |
Why?
|
Virus Diseases | 1 | 2005 | 716 | 0.040 |
Why?
|
Databases, Genetic | 2 | 2020 | 1741 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2021 | 11118 | 0.040 |
Why?
|
Camptothecin | 2 | 2014 | 591 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 304 | 0.040 |
Why?
|
Middle Aged | 7 | 2024 | 220835 | 0.040 |
Why?
|
Pyrophosphatases | 1 | 2018 | 142 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2019 | 412 | 0.040 |
Why?
|
Proteomics | 2 | 2023 | 3836 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1050 | 0.040 |
Why?
|
Primates | 1 | 2019 | 521 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2018 | 18926 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4109 | 0.030 |
Why?
|
Pore Forming Cytotoxic Proteins | 2 | 2007 | 130 | 0.030 |
Why?
|
Male | 7 | 2024 | 360675 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2005 | 1830 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1005 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2802 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2113 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 957 | 0.030 |
Why?
|
Escherichia coli | 1 | 2008 | 4205 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1084 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22157 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2018 | 1681 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2005 | 2667 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 522 | 0.030 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 109 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5033 | 0.030 |
Why?
|
DNA Helicases | 1 | 2019 | 851 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2014 | 182 | 0.030 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2014 | 70 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12727 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16572 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2227 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2007 | 3790 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58946 | 0.030 |
Why?
|
Protein Kinase C-alpha | 1 | 2014 | 113 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 961 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2020 | 5775 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 2223 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2018 | 1982 | 0.030 |
Why?
|
Hydroxyurea | 1 | 2014 | 284 | 0.030 |
Why?
|
Gene Regulatory Networks | 2 | 2014 | 1744 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7567 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 2014 | 353 | 0.030 |
Why?
|
Chromones | 1 | 2012 | 148 | 0.030 |
Why?
|
Glucose | 1 | 2024 | 4341 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2024 | 3309 | 0.020 |
Why?
|
Genetic Markers | 1 | 2018 | 2599 | 0.020 |
Why?
|
Mice, Nude | 1 | 2018 | 3604 | 0.020 |
Why?
|
Heterochromatin | 1 | 2014 | 291 | 0.020 |
Why?
|
Preoperative Period | 1 | 2014 | 551 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2012 | 237 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2004 | 9518 | 0.020 |
Why?
|
Exosomes | 1 | 2016 | 424 | 0.020 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2011 | 52 | 0.020 |
Why?
|
Piperidines | 1 | 2020 | 1656 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2020 | 2426 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2014 | 836 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 382 | 0.020 |
Why?
|
Carboplatin | 1 | 2014 | 793 | 0.020 |
Why?
|
Retinal Pigment Epithelium | 1 | 2014 | 303 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 681 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2013 | 504 | 0.020 |
Why?
|
Macrophages | 2 | 2020 | 5754 | 0.020 |
Why?
|
Radiometry | 1 | 2016 | 812 | 0.020 |
Why?
|
Chromosome Segregation | 1 | 2012 | 234 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1075 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1644 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2024 | 3951 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2019 | 6224 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6343 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2021 | 1846 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2018 | 1605 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4908 | 0.020 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2009 | 28 | 0.020 |
Why?
|
Adult | 5 | 2024 | 221083 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 367 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 17889 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3114 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2009 | 363 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2051 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39121 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2014 | 858 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2452 | 0.020 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2012 | 455 | 0.020 |
Why?
|
Staurosporine | 1 | 2009 | 241 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3594 | 0.020 |
Why?
|
Models, Chemical | 1 | 2009 | 609 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 677 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1371 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2813 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1168 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4423 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3869 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2007 | 180 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4565 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5750 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6225 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41486 | 0.020 |
Why?
|
Caspases | 1 | 2009 | 878 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3666 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2007 | 3696 | 0.020 |
Why?
|
Administration, Intravaginal | 1 | 2005 | 149 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3591 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 888 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2007 | 392 | 0.020 |
Why?
|
Megakaryocytes | 1 | 2009 | 566 | 0.020 |
Why?
|
Receptors, HIV | 1 | 2005 | 158 | 0.010 |
Why?
|
Endosomes | 1 | 2007 | 518 | 0.010 |
Why?
|
Genes, Viral | 1 | 2005 | 649 | 0.010 |
Why?
|
Prognosis | 2 | 2016 | 29672 | 0.010 |
Why?
|
Genes, Essential | 1 | 2005 | 185 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15915 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2091 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 7969 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3591 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5870 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1751 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13506 | 0.010 |
Why?
|
COS Cells | 1 | 2005 | 1129 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 5993 | 0.010 |
Why?
|
Child | 2 | 2023 | 80134 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2827 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2006 | 752 | 0.010 |
Why?
|
Arginine | 1 | 2006 | 921 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2820 | 0.010 |
Why?
|
Cervix Uteri | 1 | 2005 | 570 | 0.010 |
Why?
|
Liposomes | 1 | 2005 | 783 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 2005 | 561 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2061 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5195 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 64670 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3603 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2778 | 0.010 |
Why?
|
Erythrocytes | 1 | 2009 | 2413 | 0.010 |
Why?
|
Vagina | 1 | 2005 | 841 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4537 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14023 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1782 | 0.010 |
Why?
|
Viral Proteins | 1 | 2005 | 1798 | 0.010 |
Why?
|
Virus Replication | 1 | 2005 | 2426 | 0.010 |
Why?
|
Lung | 1 | 2016 | 9979 | 0.010 |
Why?
|
Antibodies | 1 | 2005 | 2415 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6198 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 3725 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11066 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59199 | 0.010 |
Why?
|
Genotype | 1 | 2007 | 12983 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88271 | 0.010 |
Why?
|
HIV-1 | 1 | 2005 | 6851 | 0.000 |
Why?
|
Inflammation | 1 | 2005 | 10758 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 39953 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 74219 | 0.000 |
Why?
|